Jump to content

The Michael J. Fox Foundation

From Wikipedia, the free encyclopedia
(Redirected from Michael J. Fox Foundation)
The Michael J. Fox Foundation for Parkinson's Research
AbbreviationMJFF
FoundedOctober 31, 2000; 24 years ago (2000-10-31)[1]
FounderMichael J. Fox
13-4141945[2]
Legal status501(c)(3) Non-profit
PurposeFunding research for better treatments and a cure for Parkinson's disease[2]
HeadquartersNew York City, U.S.[2]
FieldsParkinson's disease clinical research
Skip Irving[3]
Deborah W. Brooks[4]
AffiliationsMJFF Canada[2]
Websitewww.michaeljfox.org

The Michael J. Fox Foundation for Parkinson's Research is a US non-profit organization founded in 2000 by Canadian-American actor Michael J. Fox to find a cure for Parkinson's disease.

Business model

[edit]

The organization funds grants directly to scientists it assesses as having the best chance of finding a cure.[4] It maintains closer control over and supervision of projects than is typical from other medical-research foundations.[4][5]

Fundraising

[edit]

In 2006 it was the "largest private funder of research" into Parkinson's, according to The Guardian.[6] As of 2023, it had raised $2 billion for Parkinson's research projects.[7][4] According to Town and Country, in 2022 the organization funded more Parkinson's research than the US government.[4] According to Fox Business, it is the largest nonprofit funder of Parkinson's research in the world.[8]

Work

[edit]

In 2023, a longitudinal study funded by the organization, the Parkinson's Progression Markers Initiative, released results in Lancet Neurology showing Parkinson's can be detected by the presence of a biomarker protein, abnormal alpha-synuclein.[4][9][10][11] The biomarker can be detected before the onset of symptoms.[12]

The organization hosts the Fox Trial Finder, a website for presenting clinical trials in Parkinson's disease research.[13]

References

[edit]
  1. ^ "The Michael J. Fox Foundation for Parkinson's Research Archived 2016-09-20 at the Wayback Machine". Division of Corporations. Delaware Department of State. Accessed on May 18, 2016.
  2. ^ a b c d "Form 990: Return of Organization Exempt from Income Tax". The Michael J. Fox Foundation for Parkinson's Research. Guidestar. December 31, 2014.
  3. ^ "Skip Irving | Parkinson's Disease". www.michaeljfox.org. Archived from the original on 2022-12-26. Retrieved 2022-12-26.
  4. ^ a b c d e f Goldman, Andrew (2023-11-02). "Michael J. Fox Didn't Get Mad, He Got Motivated". Town & Country Magazine. Retrieved 2024-01-20.
  5. ^ Piller, Charles (2016-08-30). "As Parkinson's patients wait, Fox Foundation and scientist feud over drug trial". Stat. Retrieved 2024-01-20.
  6. ^ Pilkington, Ed (October 20, 2006). "Radio host apologises for claim Michael J Fox faked symptoms". The Guardian.
  7. ^ Burleson, Nate; Breen, Kerry (November 9, 2023). "Michael J. Fox talks funding breakthrough research for Parkinson's disease". CBS News. Archived from the original on November 24, 2023. Retrieved January 20, 2024.
  8. ^ Genovese, Daniella (2019-09-30). "Billionaire Ken Griffin, Michael J. Fox Foundation stage $10M competition for 'game-changing' Parkinson's research". Fox Business. Retrieved 2024-01-20.
  9. ^ Hodgson, J. L. (2023-04-17). "Michael J. Fox's foundation finds groundbreaking discovery about Parkinson's". Diario AS. Retrieved 2024-01-20.
  10. ^ Schnell, Mychael (2021-12-02). "Michael J. Fox Foundation studying early signs of Parkinson's disease". The Hill. Retrieved 2024-01-20.
  11. ^ Paynter, Ben (9 May 2018). "Michael J. Fox's Foundation Is Using This Alphabet Smartwatch To Research Parkinson's". Fast Company.
  12. ^ Michaud, Mark. "What You Need to Know about the New Parkinson's Biomarker". University of Rochester Medical Center. Retrieved 2024-01-20.
  13. ^ Weiner, Michael W.; Nosheny, Rachel; Camacho, Monica; Truran-Sacrey, Diana; Mackin, R. Scott; Flenniken, Derek; Ulbricht, Aaron; Insel, Philip; Finley, Shannon; Fockler, Juliet; Veitch, Dallas (August 2018). "The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies". Alzheimer's & Dementia. 14 (8): 1063–1076. doi:10.1016/j.jalz.2018.02.021. ISSN 1552-5260. PMC 6126911. PMID 29754989.
[edit]